NDC 60505-6116 – Regadenoson
Regadenoson .08 mg/mL · Injection, Solution · Intravenous
Product NDC60505-6116
Product details
- Brand name
- Regadenoson
- Generic name
- Regadenoson
- Labeler
- Apotex Corp.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA207604
- Marketed since
- March 10, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Pharmacologic Cardiac Stress Test Agent
Active ingredients
- Regadenoson .08 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 60505-6116-0 | 1 SYRINGE, PLASTIC in 1 CARTON (60505-6116-0) / 5 mL in 1 SYRINGE, PLASTIC | Mar 10, 2023 |
Other Regadenoson products
- 16729-477 Regadenoson .08 mg/mL · Injection, Solution · Accord Healthcare Inc.
- 60505-6288 Regadenoson .08 mg/mL · Injection, Solution · Apotex Corp.
- 36000-364 Regadenoson .08 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 68083-175 Regadenoson .08 mg/mL · Injection, Solution · Gland Pharma Limited
- 0641-6253 Regadenoson Anhydrous .08 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0409-1401 Regadenoson Anhydrous .08 mg/mL · Injection, Solution · Hospira, Inc.
- 83032-001 Regadenoson .08 mg/mL · Injection, Solution · Indies Pharma Jamaica Limited
- 76329-3321 Regadenoson Anhydrous .08 mg/mL · Injection, Solution · International Medication Systems, Limited
- 85742-012 Regadenoson .08 mg/mL · Injection, Solution · Kanchan Healthcare Inc
- 10135-803 Regadenoson .08 mg/mL · Injection, Solution · Marlex Pharmaceuticals, Inc.
- 71288-201 Regadenoson .08 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 43598-616 Regadenoson Anhydrous .08 mg/mL · Injection · Dr. Reddy's Laboratories Inc.